Clinical trials
Completed Phase 2 Purpura, Thrombocytopenic, Idiopathic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 5 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 2 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 43 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 4 |
| Peking University People's Hospital | 3 |
| Amgen | 2 |
| Eisai Inc. | 2 |
| Hospital Universitario Dr. Jose E. Gonzalez | 2 |
| Institute of Hematology & Blood Diseases Hospital, China | 2 |
| Novartis Pharmaceuticals | 2 |
| Shandong University | 2 |
| Weill Medical College of Cornell University | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Purpura, Thrombocytopenic, Idiopathic | 43 |
| Purpura, Thrombocytopenic | 4 |
| Thrombocytopenia | 4 |
| Purpura | 3 |
| Autoimmune Diseases | 2 |
| Hematologic Diseases | 2 |
| Rare Diseases | 2 |
| Anemia, Hemolytic, Autoimmune | 1 |
| Aortic Arch Syndromes | 1 |
| Arthritis, Rheumatoid | 1 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.